TruBridge, Inc. (TBRG)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$26.240.00%
Close 2026-07-10 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
TruBridge keeps revenue stable near $86 million per quarter. Net income improved to $506,000 in 2026-Q1 from a loss last quarter. The company raised 2025 revenue guidance to about $346.5 million. Earnings estimates have been revised up recently, showing growing confidence.
Revenue could decline below stable levels, hurting cash flow. Litigation and credit facility concerns may pressure profits. If net income fails to improve or reverses, the turnaround stalls.
The market price is about 27% below our valuation model's midpoint. Analysts expect about 5% revenue growth next year. Our view is more optimistic on earnings improvement and revenue stability.
Breaks if: net income remains negative or declines below zero
Breaks if: revenue growth falls below 4.6% YoY
Breaks if: quarterly revenue falls below $86 million
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity in the healthcare sector. The current thesis state is intact, with recent financial performance showing strength despite some volatility in management and elevated risks.
The market seems to price in a justified valuation that is expensive compared to peers. There is an expectations gap indicating that the market may not fully account for the potential upside from recent improvements in company quality and momentum.
Management has successfully completed key merger-related priorities, which could enhance operational efficiency. However, there is a near-term risk of missing earnings due to the smaller-cap nature of the company and recent misses from industry peers.
The thesis hinges on the ability of TBRG to maintain momentum in the healthcare sector, particularly if larger peers continue to perform well. Additionally, any negative guidance or economic downturns could significantly impact investor sentiment.
Overall, TBRG's prospects depend on its execution of strategic priorities and the broader market environment. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.